Clinical Trials

Study: Proof of Concept Study of Vorinostat, a Histone Deacetylase Inhibitor, in Patients with Class 2 High-Risk Uveal Melanoma
Principal Investigator: Nicolas Acquavella, MD
Co-Investigator: J. William Harbour, MD
Contact: Barbara Perez
305-326-6339
Status: Enrolling

Study: Phase 1B Trial of AEB071, a PKC inhibitor, in combination with Byl719, a PI3K Inhibitor, in Patients with Metastatic Uveal Melanoma
Principal Investigator: Lynn Feun, MD
Co-Investigator: J. William Harbour, MD
Contact: Barbara Perez
305-326-6339
Status: Enrolling

Clinical Studies

Study: Molecular Predictive Testing in Ocular Melanoma
Sub-study: Collaborative Ocular Oncology Group Uveal Melanoma Validation Study Number 2 (COOG2)
Principal Investigator: J. William Harbour, MD
Contact: Christina Decatur
305-326-6020
Status: Enrolling

Study: Molecular Profiling of Ocular Tumors
Principal Investigator: J. William Harbour, MD
Contact: Christina Decatur
305-326-6020
Status: Enrolling